Gilead Sciences's most recent trend suggests a bullish bias. One trading opportunity on Gilead Sciences is a Bull Put Spread using a strike $97.50 short put and a strike $92.50 long put offers a potential 14.68% return on risk over the next 28 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $97.50 by expiration. The full premium credit of $0.64 would be kept by the premium seller. The risk of $4.36 would be incurred if the stock dropped below the $92.50 long put strike price.
The 5-day moving average is moving up which suggests that the short-term momentum for Gilead Sciences is bullish and the probability of a rise in share price is higher if the stock starts trending.
The 20-day moving average is moving up which suggests that the medium-term momentum for Gilead Sciences is bullish.
The RSI indicator is at 47.04 level which suggests that the stock is neither overbought nor oversold at this time.
To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here
LATEST NEWS for Gilead Sciences
10 Most Popular Healthcare Stocks Among Hedge Funds
Thu, 19 Feb 2015 19:54:55 GMT
Nasdaq names leading the way
Wed, 18 Feb 2015 19:08:00 GMT
Gilead's Pill Can Stop HIV. So Why Does Almost Nobody Take It?
Wed, 18 Feb 2015 05:01:17 GMT
AbbVie: Amgen Circa 2011?
Tue, 17 Feb 2015 19:15:00 GMT
Why Gilead Sciences Doesn't Seem Too Worried About AbbVie's Hep-C Treatment
Tue, 17 Feb 2015 16:45:00 GMT
Also on Market Tamer…
Follow Us on Facebook